| Tuesday, March 10th 2020

Interview of Herantis Pharma CEO on Q4 2019 by Direkt Studios

| Friday, February 28th 2020

CDNF phase I-II clinical study webinar: Topline data of the 6-month treatment period

| Wednesday, February 26th 2020

Renishaw announces completion of the main part of a multi-centre clinical trial

| Tuesday, February 25th 2020

Herantis Pharma Plc announces topline results of Phase 1-2 CDNF trial

| Saturday, January 4th 2020

Patient Treatment Completed in Phase 1/2 Trial Testing Therapy Candidate CDNF in Parkinson’s Disease

Parkinson's News Today